Global Immunoglobulins Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends

16 Aug, 2021

The immunoglobulins market consists of sales of immunoglobulins by entities (organizations, sole traders, and partnerships) that are used to measure the level of types of antibodies in the blood. Immunoglobulins or antibodies are glycoprotein molecules generated by plasma cells (white blood cells). They are an important aspect of the immune response because they recognize and bind to certain antigens, such as bacteria or viruses, and help to destroy them.

Global Immunoglobulins Market Size And Drivers:

The global immunoglobulins market is expected to grow from $12.89 billion in 2020 to $14.56 billion in 2021 at a compound annual growth rate (CAGR) of 13%. The change in growth trend of the immunoglobulins market is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The immunoglobulins market is expected to reach $19.36 billion in 2025 at a CAGR of 7.4%. The increasing geriatric population drives the growth of the immunoglobulins market.

Request For A Sample For The Global Immunoglobulins Market Report:

Trends In The Global Immunoglobulins Market

The launch of new offices and laboratories to boost research and development activities is shaping the immunoglobulins market. Major companies operating in the immunoglobulins sector are focused on opening new laboratories for immunoglobulins to enhance the platform technology, pipeline development, and manufacturing capabilities. For instance, in February 2021, VectorY, a fully integrated gene therapy firm, has opened offices and laboratories in the Netherlands to develop novel vectorized antibodies for muscular and neurological illnesses. In this laboratory, VectorY creates exclusive and collaborative projects based on a revolutionary AAV platform and antibody-based targeted degradation technology. The company is developing a pipeline of new vectorized antibodies to treat muscle and CNS illnesses, to enhance delivery, durability, and accessibility of specific tissues and cells, to overcome the limits of present therapies.

Global Immunoglobulins Market Segments:
The global immunoglobulins market is further segmented based on product, mode of delivery, application and geography.
By Product: IgG, IgA, IgM, IgE, IgD
By Mode Of Delivery: Intravenous, Subcutaneous
By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic Thrombocytopenic Purpura (ITP), Others.
By Mode of Administration: Injectable Administration, Topical Administration, Oral Administration
By Geography: The global immunoglobulins market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the immunoglobulins market in 2020.

Read More On The Report For The Global Immunoglobulins Market At:

Immunoglobulins Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides immunoglobulins market overviews, analyzes and forecasts market size and growth for the global immunoglobulins market, immunoglobulins market share, immunoglobulins market players, immunoglobulins market segments and geographies, immunoglobulins market’s leading competitors’ revenues, profiles and market shares. The immunoglobulins market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.